AAC Holdings, Inc.

Robbins Arroyo LLP is Investigating the Officers and Directors of AAC Holdings, Inc. (AAC) on Behalf of Shareholders

Robbins Arroyo LLP is investigating whether certain officers and directors of AAC Holdings, Inc. (NYSE: AAC) breached their fiduciary duties to the company and its shareholders by intentionally deceiving investors about a criminal investigation that could adversely affect the company’s inherent value. AAC Holdings provides inpatient substance abuse treatment services for individuals with drug and alcohol addiction in the U.S.

AAC Holdings is Accused of Deceiving Investors About a Criminal Investigation

On July 1, 2016, the U.S. District Court Middle District of Tennessee, Nashville Division denied a motion to dismiss a securities fraud class action filed against AAC and certain executives. According to the complaint, AAC deceived investors about an active criminal investigation—of which the company was aware of as early as 2013 and prior to its initial public offering—by the California Department of Justice, which materialized into an indictment against AAC for, among other things, second-degree murder of an AAC patient. The complaint alleges that AAC deliberately disregarded the federal securities laws by concealing the criminal investigation at the time of its initial public offering despite being aware of the facts surrounding the investigation.

ACC Holdings Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

 

Shareholder Information

Items marked with an asterisk (*) are required information.

First Name * Last Name *
Phone *
E-mail * Confirm: E-mail *
Number of Shares Owned:
Comments:

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information
+=

    Send This Post

    Tags: